FDA label 0810c1d7-144f-4019-9c0d-c23015e3bf03

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
29e01360-5b59-4f8a-a2f4-bdabbd7dbcc5
SPL ID
0810c1d7-144f-4019-9c0d-c23015e3bf03
Version
2
Effective date
2017-02-16
Source export date
2026-10-12
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/fa098e7c5cff0b1ab653ce934059d1f4b90b860bafc0383a1f66223ce1037518/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 02:07:35

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external use only. Not for ophthalmic use. Product could harm small children if chewed or swallowed. Individual tubes are NOT child resistant. Keep product and cleansing wipes out of the reach of children.

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 2 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Dryness Perioral dermatitis Skin atrophy Itching Folliculitis Hypertrichosis Allergic contact dermatitis Striae Irritation Acneiform eruptions Maceration of the skin Miliaria Hypopigmentation Secondary infection

adverse reactions table

<table width="90%"> <col width="15%" align="left" valign="top"/> <col width="30%" align="left" valign="top"/> <col width="35%" align="left" valign="top"/> <col width="20%" align="left" valign="top"/> <tbody> <tr styleCode="TopRule"> <td>Burning</td> <td>Dryness</td> <td>Perioral dermatitis</td> <td>Skin atrophy</td> </tr> <tr> <td>Itching</td> <td>Folliculitis Hypertrichosis</td> <td>Allergic contact dermatitis</td> <td>Striae</td> </tr> <tr> <td>Irritation</td> <td>Acneiform eruptions</td> <td>Maceration of the skin</td> <td>Miliaria</td> </tr> <tr styleCode="BotRule"> <td> </td> <td>Hypopigmentation</td> <td>Secondary infection</td> <td> </td> </tr> </tbody> </table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.